Bridging the gap in the symptomatic heart failure patient journey: insights from the Italian scenario.

IF 2.9 3区医学 Q3 ENGINEERING, BIOMEDICAL

Expert Review of Medical Devices Pub Date : 2023-07-01 Epub Date: 2023-09-15 DOI:10.1080/17434440.2023.2258786

Matteo Ziacchi, Alberto Spadotto, Stefano Ghio, Marta Pellegrino, Luciano Potena, Daniele Masarone, Marco Merlo, Davide Stolfo, Maria Michela Caracciolo, Corinna Inserra, Fabrizio Ammirati, Michele Ciccarelli, Furio Colivicchi, Stefano Bianchi, Giuseppe Patti, Fabrizio Oliva, Giuseppe Arcidiacono, Roberto Rordorf, Daniela Pini, Giuseppe Pacileo, Antonio D'Onofrio, Giovanni Battista Forleo, Matteo Mariani, Francesco Adamo, Alessandro Alonzo, Matteo Ruzzolini, Chiara Ghiglieno, Manlio Cipriani, Giorgio Firetto, Nadia Aspromonte, Francesco Clemenza, Gaetano Maria De Ferrari, Michele Senni, Maria Grazia Bongiorni, Claudio Tondo, Massimo Grimaldi, Francesco Giallauria, Francesco Rametta, Procolo Marchese, Mauro Biffi, Gianfranco Sinagra

{"title":"Bridging the gap in the symptomatic heart failure patient journey: insights from the Italian scenario.","authors":"Matteo Ziacchi, Alberto Spadotto, Stefano Ghio, Marta Pellegrino, Luciano Potena, Daniele Masarone, Marco Merlo, Davide Stolfo, Maria Michela Caracciolo, Corinna Inserra, Fabrizio Ammirati, Michele Ciccarelli, Furio Colivicchi, Stefano Bianchi, Giuseppe Patti, Fabrizio Oliva, Giuseppe Arcidiacono, Roberto Rordorf, Daniela Pini, Giuseppe Pacileo, Antonio D'Onofrio, Giovanni Battista Forleo, Matteo Mariani, Francesco Adamo, Alessandro Alonzo, Matteo Ruzzolini, Chiara Ghiglieno, Manlio Cipriani, Giorgio Firetto, Nadia Aspromonte, Francesco Clemenza, Gaetano Maria De Ferrari, Michele Senni, Maria Grazia Bongiorni, Claudio Tondo, Massimo Grimaldi, Francesco Giallauria, Francesco Rametta, Procolo Marchese, Mauro Biffi, Gianfranco Sinagra","doi":"10.1080/17434440.2023.2258786","DOIUrl":null,"url":null,"abstract":"Background: The prognosis for heart failure (HF) patients remains poor, with a high mortality rate, and a marked reduction in quality of life (QOL) and functional status. This study aims to explore the ongoing needs of HF management and the epidemiology of patients followed by Italian HF clinics, with a specific focus on cardiac contractility modulation (CCM).Research design and methods: Data from patients admitted to 14 HF outpatients clinics over 4 weeks were collected and compared to the results of a survey open to physicians involved in HF management operating in Italian centers.Results: One hundred and five physicians took part in the survey. Despite 94% of patients receive a regular follow-up every 3-6 months, available therapies are considered insufficient in 30% of cases. Physicians reported a lack of treatment options for 23% of symptomatic patients with reduced ejection fraction (EF) and for 66% of those without reduced EF. Approximately 3% of HF population (two patients per month per HF clinic) meets the criteria for immediate CCM treatment, which is considered a useful option by 15% of survey respondents.Conclusions: Despite this relatively small percentage, considering total HF population, CCM could potentially benefit numerous HF patients, particularly the elderly, by reducing hospitalizations, improving functional capacity and QOL.","PeriodicalId":12330,"journal":{"name":"Expert Review of Medical Devices","volume":" ","pages":"951-961"},"PeriodicalIF":2.9000,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Expert Review of Medical Devices","FirstCategoryId":"5","ListUrlMain":"https://doi.org/10.1080/17434440.2023.2258786","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2023/9/15 0:00:00","PubModel":"Epub","JCR":"Q3","JCRName":"ENGINEERING, BIOMEDICAL","Score":null,"Total":0}

引用次数: 0

Abstract

Background: The prognosis for heart failure (HF) patients remains poor, with a high mortality rate, and a marked reduction in quality of life (QOL) and functional status. This study aims to explore the ongoing needs of HF management and the epidemiology of patients followed by Italian HF clinics, with a specific focus on cardiac contractility modulation (CCM).

Research design and methods: Data from patients admitted to 14 HF outpatients clinics over 4 weeks were collected and compared to the results of a survey open to physicians involved in HF management operating in Italian centers.

Results: One hundred and five physicians took part in the survey. Despite 94% of patients receive a regular follow-up every 3-6 months, available therapies are considered insufficient in 30% of cases. Physicians reported a lack of treatment options for 23% of symptomatic patients with reduced ejection fraction (EF) and for 66% of those without reduced EF. Approximately 3% of HF population (two patients per month per HF clinic) meets the criteria for immediate CCM treatment, which is considered a useful option by 15% of survey respondents.

Conclusions: Despite this relatively small percentage, considering total HF population, CCM could potentially benefit numerous HF patients, particularly the elderly, by reducing hospitalizations, improving functional capacity and QOL.

查看原文本刊更多论文

弥合症状性心力衰竭患者旅程中的差距：来自意大利场景的见解。

背景：心力衰竭（HF）患者的预后仍然很差，死亡率很高，生活质量（QOL）和功能状态显著降低。本研究旨在探讨意大利HF诊所对HF管理和患者流行病学的持续需求，研究设计和方法：收集14家HF门诊诊所4周内收治的患者的数据，并与意大利中心参与HF管理的医生进行的调查结果进行比较。结果：105名医生参加了调查。尽管94%的患者每3-6年接受一次定期随访几个月后，30%的病例认为可用的治疗方法不足。据医生报告，23%的射血分数（EF）降低的有症状患者和66%的EF未降低的患者缺乏治疗选择。大约3%的HF人群（每个HF诊所每月两名患者）符合立即CCM治疗的标准，15%的调查受访者认为这是一个有用的选择。结论：尽管这一比例相对较小，但考虑到HF的总人群，CCM可以通过减少住院人数、提高功能能力和生活质量，使许多HF患者，尤其是老年人受益。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Expert Review of Medical Devices 医学-工程：生物医学

CiteScore

5.90

自引率

3.20%

发文量

审稿时长

6-12 weeks

期刊介绍： The journal serves the device research community by providing a comprehensive body of high-quality information from leading experts, all subject to rigorous peer review. The Expert Review format is specially structured to optimize the value of the information to reader. Comprehensive coverage by each author in a key area of research or clinical practice is augmented by the following sections: Expert commentary - a personal view on the most effective or promising strategies Five-year view - a clear perspective of future prospects within a realistic timescale Key issues - an executive summary cutting to the author''s most critical points In addition to the Review program, each issue also features Medical Device Profiles - objective assessments of specific devices in development or clinical use to help inform clinical practice. There are also Perspectives - overviews highlighting areas of current debate and controversy, together with reports from the conference scene and invited Editorials.